BASSAM GHANEM MD NPI 1528167830

NPI Information

  • NPI: 1528167830
  • Provider Name: BASSAM GHANEM, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 425 HAALAND DR STE 101
    THOUSAND OAKS, CA
    ZIP 91361
  • Phone: (805) 496-2949

Map and Directions

Get Directions

NPI Details

Bassam Ghanem, MD is a hematology and oncology internal medicine in Thousand Oaks, CA. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Bassam Ghanem, MD NPI is 1528167830. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

425 HAALAND DR STE 101
THOUSAND OAKS, CA
ZIP 91361-230
Phone: (805) 496-2949
Fax: (805) 204-4076

The NPI 1528167830 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (HCPCS:99233)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes (HCPCS:99223)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (HCPCS:99232)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes (HCPCS:99222)

The enumeration date for this NPI number is 9/22/2006 and was last updated on 3/23/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyA97459CALIFORNIANo
2207RH0003XInternal MedicineHematology & OncologyA97459CALIFORNIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.